Cargando…
CSF3 Is a Potential Drug Target for the Treatment of COVID-19
Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease that appeared at the end of 2019. As of July 2020, the cumulative number of infections and deaths have exceeded 15 million and 630,000, respectively. And new cases are increasing. There are still many difficulties surroun...
Autores principales: | Fang, Chao, Mei, Jie, Tian, Huixiang, Liou, Yu-Ligh, Rong, Dingchao, Zhang, Wei, Liao, Qianjin, Wu, Nayiyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862719/ https://www.ncbi.nlm.nih.gov/pubmed/33551833 http://dx.doi.org/10.3389/fphys.2020.605792 |
Ejemplares similares
-
Cellular models of development of ovarian high‐grade serous carcinoma: A review of cell of origin and mechanisms of carcinogenesis
por: Mei, Jie, et al.
Publicado: (2021) -
Akt: A Potential Drug Target for Metabolic Syndrome
por: Miao, Runyu, et al.
Publicado: (2022) -
Editorial: Cigarette Smoke, E-Cigarette/E-Vaping and COVID-19: Risks and Implications in This New Era
por: Camoretti-Mercado, Blanca, et al.
Publicado: (2021) -
Caveolin as a potential drug target for cardiovascular protection
por: Sellers, Stephanie L., et al.
Publicado: (2012) -
SRC-3/TRAF4 facilitates ovarian cancer development by activating the PI3K/AKT signaling pathway
por: Wang, Ying, et al.
Publicado: (2023)